When comparing the two groups after 4 weeks of treatment , gastrointestinal symptoms ( 29 8.8 vs 46 10.5 ; P < 0.001 ) and quality of life ( 102.4 5.1 vs 96 6.1 ; P = 0.021 ) were significantly better in Group I than group II .